Disease and Economic Burden of Kashin-Beck Disease - China, 2021‎

China CDC Wkly. 2024 Jan 12;6(2):40-44. doi: 10.46234/ccdcw2024.009.

Abstract

What is already known about this topic?: Kashin-Beck disease (KBD) is a chronic and degenerative osteoarthropathy characterized by cartilage degeneration. It is an endemic disease that is highly prevalent among the Chinese population and poses a significant health risk.

What is added by this report?: This is the first national report on the economic burden of KBD in China. According to the data from 2021, KBD has caused significant disease and economic burdens. The most substantial reduction in healthy life expectancy was observed among patients with degree II severity and those aged 60 years and older, resulting in a total indirect economic burden of 112.74 million Chinese Yuan (CNY).

What are the implications for public health practice?: The results of this study will contribute to informing the development of tailored prevention and control strategies by the government. These strategies will include targeted policies and recommendations for appropriate healthcare and financial subsidies, which will be based on the demographic characteristics of the endemic areas.

Keywords: Disease burden; Economic burden; Kashin-Beck disease.

Grants and funding

This study was supported by the Heilongjiang Postdoctoral Foundation 2022, National Key Research and Development Program of China (2022YFC2503101), National Natural Science Foundation of China (81972983) and the Central Government Subsidy for Local Public Health Special Fund for Endemic Disease Prevention and Control Project 2002–2021